Australia markets closed

Viridian Therapeutics, Inc. (VRDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
13.27-0.98 (-6.88%)
As of 01:35PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12121412
Avg. Estimate-1.1-1.11-4.54-4.57
Low estimate-1.36-1.34-5.72-6.69
High estimate-0.81-0.84-3.44-3.23
Year ago EPS-1.61-1.27-5.31-4.54
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts11111110
Avg. Estimate70k70k270k7.23M
Low estimateN/AN/AN/AN/A
High estimate500k500k2M40.7M
Year ago sales110k72k314k270k
Sales growth (year/est)-36.40%-2.80%-14.00%2,577.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.02-1.29-1.27-1
Actual EPS-1.61-1.27-1.09-1.35
Difference-0.590.020.18-0.35
Surprise %-57.80%1.60%14.20%-35.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.1-1.11-4.54-4.57
7 days ago-1.1-1.11-4.54-4.57
30 days ago-1.1-1.11-4.54-4.57
60 days ago-0.94-0.96-4.18-4.27
90 days ago-0.95-0.98-4.21-4.3
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesVRDNIndustrySector(s)S&P 500
Current qtr.31.70%N/AN/AN/A
Next qtr.12.60%N/AN/AN/A
Current year14.50%N/AN/AN/A
Next year-0.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A